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Endosomal sorting complexes required for trans-
port (ESCRTs) are essential for ubiquitin-dependent
degradation of mitogenic receptors, a process often
compromised in cancer pathologies. Sorting of ubiq-
uinated receptors via ESCRTs is controlled by the
tumor suppressor phosphatase HD-PTP. The spe-
cific interaction between HD-PTP and the ESCRT-I
subunit UBAP1 is critical for degradation of growth
factor receptors and integrins. Here, we present the
structural characterization by X-ray crystallography
and double electron-electron resonance spectros-
copy of the coiled-coil domain of HD-PTP and its
complex with UBAP1. The coiled-coil domain adopts
an unexpected open and rigid conformation that
contrasts with the closed and flexible coiled-coil
domain of the related ESCRT regulator Alix. The
HD-PTP:UBAP1 structure identifies the molecular
determinants of the interaction and provides a mo-
lecular basis for the specific functional cooperation
between HD-PTP and UBAP1. Our findings provide
insights into the molecular mechanisms of regulation
of ESCRT pathways that could be relevant to anti-
cancer therapies.
INTRODUCTION
Ubiquitination, endocytosis, and degradation of cell-surface
receptors constitute a major mechanism of regulation of signal
transduction by downregulating receptor availability for inter-
action with extracellular ligands. Receptor ubiquitination or
degradation are often compromised in cancer pathologies, re-
sulting in hyperactivation of signaling pathways promoting cell
transformation and tumorigenesis. HD-PTP (His domain protein
tyrosine phosphatase; PTPN23) is a non-receptor tumor sup-
pressor phosphatase (Kok et al., 1997; Toyooka et al., 2000)
that regulates several ubiquitin-dependent endosomal traf-
ficking processes such as downregulation of EGFR andPDGFRb
signaling (Doyotte et al., 2008; Ma et al., 2015), recycling of SrcStructure 24, 2115–2126, Dece
This is an open access article und(Chen et al., 2012; Lin et al., 2011), and degradation of a5b1
integrin (Kharitidi et al., 2015). Consequently, loss of HD-PTP
promotes cell proliferation, cell migration, and invasion (Chen
et al., 2012; Kharitidi et al., 2015; Lin et al., 2011; Ma et al.,
2015; Mariotti et al., 2009). It has been recently reported that
HD-PTP haploinsufficiency predisposes mice to tumorigenesis,
while hemizygous HD-PTP deletions are observed in many hu-
man cancers (Manteghi et al., 2016).
HD-PTP drives the degradation of mitogenic receptors by
coordinating their sorting into the multivesicular body (MVB)
via specific recruitment of different endosomal sorting com-
plexes required for transport (ESCRTs) (Ali et al., 2013; Stefani
et al., 2011). ESCRTs (named ESCRT-0, -I, -II, and -III) are
multimeric protein complexes that drive membrane remodeling
and scission in a number of important cellular events, including
cytokinesis, autophagy, membrane repair, and virus budding
(Hurley, 2015). Pathway selectivity is defined by different
subsets of ESCRTs and specialized adaptor Bro1 proteins:
Bro1 in yeast, HD-PTP and Alix in animals (Bissig and Gruen-
berg, 2014; Ichioka et al., 2007; Kim et al., 2005). However,
the mechanisms by which Bro1 proteins regulate the different
ESCRT pathways remain poorly understood. For example,
Alix is a general ESCRT-III regulator that supports multiple
ESCRT-dependent processes (Bissig and Gruenberg, 2014;
Carlton and Martin-Serrano, 2007; Morita et al., 2007; Schmidt
et al., 2004; Sun et al., 2015; von Schwedler et al., 2003). In
contrast, HD-PTP function is largely restricted to the early
endosome (Doyotte et al., 2008; Parkinson et al., 2015) where
it acts in close cooperation with ESCRT-0 (Ali et al., 2013)
and UBAP1 (ESCRT-I) to downregulate multiple ubiquitinated
cargoes (Agromayor et al., 2012; Kharitidi et al., 2015).
UBAP1 is an ubiquitin-binding ESCRT-I subunit that acts exclu-
sively in MVB sorting (Stefani et al., 2011; Wunderley et al.,
2014) and, like for HD-PTP (Cheng et al., 1998; Toyooka
et al., 2000), haploinsufficiency of UBAP1 is linked to naso-
pharyngeal carcinoma (Qian et al., 2001). UBAP1 is also a
risk factor for familial frontotemporal lobar degeneration (Rollin-
son et al., 2009).
HD-PTP has a multidomain organization that allows coordi-
nated binding to several ESCRTs (Figure 1). Knowledge of the
three-dimensional architecture of HD-PTP and its mode of bind-
ing to the different ESCRTs is critical for understanding how
these functional interactions are regulated. To date, structuralmber 6, 2016 ª 2016 The Authors. Published by Elsevier Ltd. 2115
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Crystallographic Structure of
HD-PTPCC
(A) Diagramof HD-PTP domain structure indicating
domain boundaries and sites of interaction for
ESCRT partners. The position of the conserved
FYX2L motif in the CC domain is shown, as well as
the FPXL motif in UBAP1.
(B) Cartoon diagram of the HD-PTPCC crystal
structure. HD-PTPCC resembles an ice hockey
stick, where the N-terminal region represents the
blade and the C-terminal region is the shaft. The
seven a helices are labeled H1 to H7, with H7 being
the central and longest helix extending the whole
length of the structure.
(C) Coiled-coil motifs in the HD-PTPCC structure
after analysis with SOCKET (Walshaw and Woolf-
son, 2001). HD-PTPCC contains two canonical
coiled coils: one two-stranded coiled coil (2st-cc)
in the blade and one three-stranded coiled coil
(3st-cc) in the shaft.
(D) Topology diagramof the structure of HD-PTPCC
showing the arrangement of the seven a helices.
(E) Superimposition of the HD-PTPCC (red) and
AlixV (blue) structures. The AlixV crystal structure
(PDB: 2OJQ) shows a V-shaped helical protein in a
closed conformation, in contrast to the open and
extended conformation of HD-PTPCC. The two
arms in AlixV are labeled.
(F) Superposition of the structures of AlixV
(blue) and yeast Bro1V (orange, PDB: 4JIO). Both
structures contain two arms joined by flexible
loops.information on HD-PTP is only available for its N-terminal Bro1
domain (Lee et al., 2016; Sette et al., 2011), which binds
ESCRT-0 and ESCRT-III (Ali et al., 2013; Doyotte et al., 2008;
Toyooka et al., 2000). Structures for the coiled-coil (CC) domains
of other Bro1 proteins, Alix and yeast Bro1, have been reported
(Fisher et al., 2007; Lee et al., 2007; Pashkova et al., 2013) and
they show a V-shaped conformation, with two arms connected
by a flexible hinge region (Figure 1). However, the CC domain
of HD-PTP has very low homology (17%–19%) to those of Alix
or Bro1, suggesting that significant structural disparity may
exist. The CC domain of HD-PTP is solely responsible for the
interaction with UBAP1, and residue F678 in this domain is
essential for binding (Stefani et al., 2011). This Phe residue2116 Structure 24, 2115–2126, December 6, 2016is part of a FYX2L motif (Figure 1)
conserved in all Bro1 proteins (Kimura
et al., 2015). In Alix, the FYX2L motif is
located on the second arm of the CC
domain and mediates binding to viral
Gag proteins (Fisher et al., 2007; Lee
et al., 2007; Zhai et al., 2008). Paradoxi-
cally, the presence of the FYX2L motif in
Alix is not sufficient for binding to
UBAP1 (Stefani et al., 2011), indicating
that other structural determinants may
be important to define selectivity.
To address this paradox and to provide
new insight into the regulation of ESCRT
function by HD-PTP, we have determinedthe crystal structures of the CC domain of HD-PTP (HD-PTPCC)
alone and in complex with UBAP1. The structures show an unex-
pected open conformation of the CC domain, strikingly different
from the V domains of Alix and yeast Bro1 (Fisher et al., 2007; Lee
et al., 2007; Pashkova et al., 2013). We propose that this open
conformation is critical to explain the selective binding of
UBAP1 to HD-PTPCC but not to Alix. The HD-PTPCC binding
interface with UBAP1 was also analyzed by nuclear magnetic
resonance (NMR), paramagnetic relaxation enhancement
(PRE), and surface plasmon resonance (SPR), and validated
through site-directed mutagenesis and functional cell-based as-
says, thus establishing the structural basis for the functional
cooperation between HD-PTP and UBAP1.
Table 1. Crystallographic Data Collection and Refinement
Statistics
apo-HD-PTPCC HD-PTPCC–UBAP1C
Data Collection
Space group P21 P21 21 21
Cell dimensions
a, b, c (A˚) 53.5, 47.7, 172.7 48.9, 93.3, 102.2
a, b, g () 90.0, 96.0, 90.0 90.0, 90.0, 90.0
Molecules per
asymmetric unit
2 1
Resolution (A˚) 2.54 (2.63–2.54)a 2.55 (2.64–2.55)
Rmerge 0.1 (0.8) 0.1 (0.8)
I/sI 19.3 (3.8) 13.6 (2.5)
Completeness (%) 98 (100) 100 (100)
Redundancy 13.5 (13.8) 6.3 (6.6)
Refinement
Resolution (A˚) 2.54 2.55
No. of reflections 28,609 15,835
Rwork/Rfree 21.7/27.8 20.9/25.4
No. of atoms 5,156 2,725
Protein 4,991 2,639
Peptide NA 73
Water 80 31
B factors
Protein 49.1 73.6
Peptide NA 89.7
Water 45.6 56.5
Root-mean-square deviations
Bond lengths (A˚) 0.009 0.003
Bond angles () 1.0 0.5
Each structure was determined from one crystal.
aValues in parentheses are for the highest-resolution shell.RESULTS
HD-PTPCC Adopts an Open and Extended Conformation
The crystallographic structure of HD-PTPCC (apo-HD-PTPCC),
determined at 2.5 A˚ resolution (Table 1), shows an elongated
architecture with seven a helices (H1–H7) whose main feature
is a central helix of 105 residues (H7) extending the whole length
of the molecule (Figure 1B). The overall shape resembles that of
an ice hockey stick, in which H1, H6, and the N-terminal region of
H7 form the blade, and H2–H5 and the rest of H7 form the shaft
(Figure 1B). The maximal dimension of HD-PTPCC is approxi-
mately 155 A˚ from end to end. Analysis of the structure using
SOCKET (Walshaw andWoolfson, 2001) identified two canonical
coiled-coil motifs: one antiparallel two-stranded coil involving
helices H6 and H7 in the blade and an extensive antiparallel,
tightly packed three-stranded coil involving helices H3, H4,
and H7 in the shaft (Figure 1C). The topology of HD-PTPCC is
such that the polypeptide chain crosses three times over the
length of the protein (Figure 1D).
The extended shape of HD-PTPCC differs markedly from the V
domains of Alix (AlixV) and yeast Bro1 (Bro1V) (Figures 1E and 1F)
(Fisher et al., 2007; Lee et al., 2007; Pashkova et al., 2013). TheseV domains are built from two arms joined by three unstructured
loops, forming a flexible hinge (Figures 1E and 1F). By contrast, in
HD-PTPCC, helix H7 forms a continuous backbone (Figures 1B
and 1D) that confers rigidity to the molecule.
HD-PTPCC Shows Limited Local Conformational
Flexibility but No Large Structural Rearrangements
Conformational flexibility between the two arms of AlixV and
Bro1V has been reported (Pashkova et al., 2013; Pires et al.,
2009). We investigated the potential flexibility of HD-PTPCC
using double electron-electron resonance (DEER) spectroscopy
(Figure 2). This technique allows the measurement of dipolar
coupling interactions between methanethiosulfonate spin labels
(MTSL), covalently attached to cysteines (Figure S1). This was
used here to estimate average distances between the labels
(Figure 2). Comparison of these distances with those obtained
from labelsmodeled on the HD-PTPCC crystal structure provided
information on the conformational dynamics of HD-PTPCC.
We conducted DEER experiments on wild-type (WT) HD-PTPCC
triply labeled at C425, C628, and C697, the three cysteines present
in the CC domain, and on doubly labeled mutants where each
cysteine in turn had been changed to serine (Figure 2).
Significantly, the C425S mutant, doubly labeled at C628-C697
(Figure 2Ai), gave no resolved dipolar coupling, indicating that
the spin labels must be separated by more than 7 nm (the
maximalmean distance observable in a 6 mswindow) (Figure S1).
This is consistent with the extended conformation observed in
the HD-PTPCC crystal structure, where the distance between
labels on C628 and C697 is 9.9 nm (Figure 2C). Likewise, the inter-
spin distance between C425 andC697 was estimated to be 6.3 nm
(Figures 2Aii and 2Aiii), which matches very well with the 6.0 nm
on the crystal structure (Figure 2C).
However, the interspin distance between C628 and C425
estimated at 4.2 nm (Figures 2Aii and 2Aiv) differs from the dis-
tance of 5.4 nm on the crystal structure (Figure 2C), suggesting
some local conformational flexibility around C425. This residue
is located in helix H2, which is connected by two flanking loops
to helices H1 and H3 (Figure 1). These loops are poorly defined in
the electron density maps, indicating backbone flexibility in that
region. Molecular dynamics simulations around helix H2 also
showed that this helix could easily adopt alternative orientations
compatible with the DEER results, without requiring large overall
conformational changes (Figures 2D and S2).
To confirm the above analyses, an additional Cys residue was
engineered at position 521 in H4 and residues C425 and C697
were changed to Ser. In this case, the mean interspin distance
between C628 and C521 (4.9 nm, Figure 2Av) was in good agree-
ment with the distance on the crystal structure (5.4 nm, Fig-
ure 2E). The DEER analysis is therefore consistent with an overall
rigid conformation for HD-PTPCC that can accommodate local
flexibility without global rearrangements, ruling out a poten-
tial mechanism of regulation by large-scale flexibility of the CC
domain.
Identification of the Minimal UBAP1 Binding Region to
HD-PTP
Specific interaction with UBAP1 is central to the function of
HD-PTP (Stefani et al., 2011), and their cooperation is essential
to regulate integrin signaling and cell migration (Kharitidi et al.,Structure 24, 2115–2126, December 6, 2016 2117
Figure 2. DEER Spectroscopy of HD-PTPCC
(A) DEER distance distributions (black) and crystal
structure-based predictions (red) are shown for all
the experiments using triply labeled HD-PTPCC (ii),
or doubly labeled (i, iii, iv, v). Colored boxes from
DEERAnalysis (Jeschke et al., 2006) are shown:
green is reliable mean, width, and shape; yellow is
reliable mean and width; orange is reliable mean;
and red indicates long-range distance.
(B) Structure of MTSL-labeled cysteine.
(C) HD-PTPCC structure with modeled MTSL labels
at C425, C628, and C697. Mean experimental DEER
(black) and predicted (red) distances are shown.
(D) HD-PTPCC structure (red) and model obtained
after TAMDS (blue) showing displacement of H2
(where C425 is located) and movement of flanking
loops. The predicted distance (blue) between labels
at C425 and C628 shows agreement with experi-
mental DEER distances (black).
(E) HD-PTPCC structure with modeled MTSL labels
at C521 and C628. Mean experimental DEER (black)
and predicted (red) distances are shown.2015). Therefore, we aimed to define this interaction at the
molecular level. We previously identified the central region of
UBAP1 (122–309) as binding to the CC domain of HD-PTP in a
yeast two-hybrid (Y2H) screen (Stefani et al., 2011). We now
have confirmed the interaction by co-immunoprecipitation of
in vitro translated full-length UBAP1 with bacterially expressed
HD-PTPCC (Figure S3). In addition, we have also shown the
interaction between UBAP1 and HD-PTPCC in cells. For these
experiments, a chimera of FKBP12 fused to HD-PTPBro1-CC
(FKBP-HD-PTPBro1-CC) was co-expressed with a chimera of
FRB (FKBP12-rapamycin binding) fused to a mitochondrial tar-
geting sequence (mito-FRB). Treatment of cells with rapamycin
caused the efficient relocalization of HD- PTPBro1-CC to mito-
chondria. Under these conditions, UBAP1-GFP, but not GFP,
also relocated to mitochondria (Figure 3A).
Further truncations of UBAP1 (122–309) identified residues
260–269 as the minimal region for effective binding to HD-PTP
(Figure 3B). This region contains an FPXL motif that resembles
the YPXnL motif conserved within viral Gag late domains and
other substrate proteins that bind to the V domain of Bro1 pro-
teins (Kimura et al., 2015; Lee et al., 2007; Zhai et al., 2008,
2011). The F268S mutation in this motif abolished binding to
HD-PTP, while the P269A or L271Amutations had no obvious ef-
fect on binding in the Y2H assays (Figures 3A and 3B). This sug-
gests that UBAP1 F268 forms a critical interaction with HD-PTP.
To further characterize this interaction, immobilized HD-PTPCC,
HD-PTPBro1-CC, andHD-PTPBro1were tested in biosensor binding
experiments (SPR) using a UBAP1 peptide containing residues2118 Structure 24, 2115–2126, December 6, 2016261–280 (UBAP1C) as the analyte. Affin-
ities of UBAP1C to HD-PTPCC and HD-
PTPBro1-CC were similar, with dissociation
constants Kd of 66.3 mM and 31.9 mM,
respectively (Figures 3C and 3D). No
binding was observed to HD-PTPBro1 (Fig-
ure 3D), thus confirming that the main
UBAP1-binding region is within the CC
domain, and that the conformation of theCC domain is functionally competent, both on its own and in the
presence of the Bro1 domain.
Mapping the Molecular Interface between HD-PTPCC
and UBAP1C
In order to define the molecular interactions, we determined the
crystal structure of HD-PTPCC in complex with UBAP1C at 2.5 A˚
resolution (Table 1). UBAP1C adopts a rather extended confor-
mation and binds to the shaft, near the core of the three-strand
coiled coil, between H4 and H7 (Figure 4A and Figure 1C).
Only residues 262–271 from UBAP1C were clearly identified in
the electron density maps (Movie S1) and the side chains of
I263, L266, F268, P269, and L271 are in direct contact with
HD-PTPCC (Figure 4). Residues 272–280 were disordered and
not visible, probably because of weaker affinity. Interactions
between UBAP1C and HD-PTPCC are mainly hydrophobic, with
hydrogen bonds only present between K671 on HD-PTPCC and
the main chain of I263, K264, and L266 on UBAP1C (Figure 4B).
We confirmed the molecular interface between HD-PTPCC-
UBAP1C using NMR by comparing the
1H 13C-heteronuclear
single quantum coherence (HSQC) spectra of UBAP1C in the
absence and presence of HD-PTPCC. Significant peak broad-
ening was only observed for residues 261–271 in the presence
of HD-PTPCC (Figures 5A, 5B, and S4), consistent with the inter-
actions observed in the crystal structure, and with the minimal
UBAP1 binding region identified by Y2H (Figure 3B).
The binding interface in HD-PTPCC is defined by three hydro-
phobic pockets (A–C in Figure 4) and the conserved FYX2L motif
Figure 3. Minimal Binding Region in UBAP1
Responsible for Interaction with HD-PTP
(A) HeLa cells transfected with FKBP-HD-
PTPBro1-CC-myc, Mito-FRB, and either GFP,
UBAP1-GFP wild-type, or UBAP1-GFP F268S
were treated with rapamycin and imaged by
immunofluorescence for GFP, myc, and mito-
chondrial Hsp70. Scale bar, 10 mm. Upon treat-
ment, UBAP1-GFP translocates to mitochondria
colocalizing with FKBP-HD-PTPBro1-CC but not
GFP or UBAP1-GFP F268S.
(B) Yeast two-hybrid interactions between UBAP1
fragments and HD-PTPBro1-CC. +/ symbols indi-
cate the degree of growth.
(C)Biosensorbinding isotherms for thedifferentHD-
PTP constructs to UBAP1C. Affinity to HD-PTPCC,
and HD-PTPBro1-CC was similar, with dissociation
constants Kd of 66.3 ± 0.35 mM and 31.9 ± 0.85 mM,
respectively. Error bars represent the SEM, n = 3.
(D) Biosensor sensograms for the immobilized
HD-PTP constructs binding to UBAP1C peptide,
showing that the CC domain is responsible for
binding since HD-PTPBro1 fails to bind to UBAP1C.plays a critical role in the interaction. The aryl ring of HD-PTPCC
F678 forms a wall that divides pockets B and C and contributes
to multiple hydrophobic interactions with UBAP1C (Figure 4).
Pocket A is large and shallow and accommodates UBAP1C res-
idues I263 and L266. This pocket is lined by T511, L515, A518
(H4 helix) and A664, L668, K671 (H7 central helix). Pocket B
is deep and narrow and accommodates UBAP1C F268 and
P269. This pocket includes A508, T511 (H4), L445 (H3), and
G675, F678 and Y679 (H7), forming extensive contacts with
the aryl ring of F268. Pocket C accommodates L271 and in-
cludes V504 (H4) and L682 (H7). This pocket is closed off by a
high rim provided by the side chains of K500, Y501 (H4), and
K685 (H7) (Figure 4B).
The tight fit of F268 in the B pocket explains the key role of this
residue for binding to HD-PTP, as shown by Y2H (Figure 3).
Conversely, UBAP1C P269 and L271 show fewer contacts with
HD-PTPCC: V504 and F678 near pocket B, and V504 and L682
in pocket C, respectively (Figure 4). The minor contribution
of these two residues to the binding interface explains the
weaker phenotype observed for the single mutations P269A
and L271A (Figure 3), particularly in the presence of F268, which
is themain anchor into the binding site. Hydrogen bonds are only
present between the side chain of HD-PTPCC K671 in pocket A
and the main chain of I263, K264, and L266 in UBAP1C
(Figure 4B).
Pocket A is partially occluded in the structure of apo-HD-
PTPCC (Figure 4E) by the side chains of K671, D667, and E514.StructuBinding of UBAP1C thus requires re-
arrangement of these three side chains
(Figure 4F). In the apo-HD-PTPCC struc-
ture, D667 and K671 form a salt bridge,
and the carboxyl group of E514 is about
6.4–7 A˚ to D667 and K671 (Figure 4F).
Upon UBAP1C binding, E514, D667, and
K671 side chains are displaced breaking
the K671-D667 salt bridge and openingthe A pocket. K671-Nz then forms hydrogen bonds with the
C=O groups of I263, K264, and L266 in UBAP1C (Figure 4B).
The orientation of UBAP1C in the HD-PTPCC binding site was
validated in PRE experiments with MTSL labels at C425 and
C628. Dipolar interaction with the electron spin label causes an
additional component of the transverse relaxation of the NMR
signal, which has strong distance dependence with maximal ef-
fect below 40 A˚. The paramagnetic enhancement in this case is
dominated by the spin label attached to C425, which is closer to
the UBAP1C binding site. Consistent with this, NMR resonances
from the N-terminal end of the UBAP1C showed enhancement
of their relaxation properties and therefore loss of peak intensity
in the presence of the MTSL label (oxidized form), whereas
those from the region beyond L271 (>40 A˚ from the label) did
not (Figure 5C), thus confirming the orientation of UBAP1C at
the binding site.
Structural Basis for the Specific Functional Interaction
of UBAP1 with HD-PTP
All Bro1 proteins contain a conserved FYX2L motif essential for
binding to their substrate proteins, which contain a reciprocally
conserved YPXnL motif (Kimura et al., 2015). Several structures
of Alix in complex with retroviral Gag late-domain peptides
(Fisher et al., 2007; Lee et al., 2007) (Figure 6) have shown that
these conserved motifs interact with each other, thus confirming
their functional importance. The FY pair in the FYX2L motif in Alix
stacks against Y in the Gag peptide YPXnLmotif, thereby servingre 24, 2115–2126, December 6, 2016 2119
Figure 4. Crystal Structure of the HD-
PTPCC-UBAP1C Complex and Analysis of
the Binding Interface
(A) Structure of HD-PTPCC (red cartoon) in complex
withUBAP1C (space-filling) showing that thebinding
site is located in the middle of the shaft region.
(B) Overview of UBAP1C (sticks) binding site in
HD-PTP. The three helices in HD-PTP that form the
binding site in the shaft are labeled (red) and repre-
sented as cartoons. Residue side chains that partic-
ipate in interactionswithUBAP1Careshownassticks
and labeled (black). Residue K671 forms hydrogen
bond interactions (cyan dashed lines) with three
carbonyl oxygens in the UBAP1C peptide (sticks).
(C) Detail of the UBAP1C binding site (pocket B)
showing the HD-PTPCC residues in the conserved
FYXnL motif: F678, Y679, and L682 forming hy-
drophobic interactions with the UBAP1c F268,
P269, and L271 in the FPXL motif.
(D) Electrostatic surface of HD-PTPCC at the
UBAP1C binding site showing three main pockets
A–C (yellow circles) that accommodate the pep-
tide. UBAP1C is shown as sticks. Residues in
UBAP1C that interact with HD-PTPCC are labeled:
I263, L266 bind to pocket A; F268 and P269 bind
to pocket B; L271 binds to pocket C.
(E) Electrostatic surface of the structure of apo-HD-PTPCC showing that pocket A is occluded by the side chains of K671 and D667, forming a salt bridge
(yellow arrow).
(F) Detail of the structure of apo-HD-PTPCC (white ribbon left) and HD-PTPCC in complex with UBAP1C (green ribbon center). In the complex, the side chains of
K671 and D667 are shifted (middle panel) and the salt bridge that they form in the apo structure (left panel) is lost. The side chain of E514 is also displaced,
making room to accommodate the peptide in pocket A (right panel).as the main anchoring point for their interaction (Fisher et al.,
2007; Lee et al., 2007). Similar binding motifs are found in
HD-PTP (FYADL) and UBAP1 (FPTL), yet the binding of UBAP1
to HD-PTP is surprisingly highly selective (Stefani et al., 2011).
In our HD-PTPCC-UBAP1C structure, the FY pair (F678, Y679)
in HD-PTP forms stacking interactions with F268 in the FPXL
motif of UBAP1C (Figure 4). The critical importance of these
residues for binding was confirmed by SPR, where both the
HD-PTP F678D and UBAP1 F268S mutations abolished binding
(Figure 7A).
Despite similarities in the molecular recognition motifs, impor-
tant differences are apparent when comparing the structures of
HD-PTPCC-UBAP1C and AlixBro1-V-Gag peptide complexes.
First, the binding site of UBAP1C is displaced with respect to
that of the Gag peptides (Figure 6A): UBAP1C occupies pocket
A in HD-PTPCC, which is poorly conserved in Alix and does not
participate in Gag peptide binding (Figures 6 and S5). This
displacement is possible because the architecture of HD-PTPCC
offers an open, extended interface suitable to accommodate
UBAP1C. In contrast, in all the complexes of AlixBro1-V with Gag
peptides, both arms of the V domain form an apex that makes
pocket A inaccessible, thus preventing binding due to steric
hindrance (Figure 6). Second, in Alix, there is a hydrophobic
binding groove that accommodates the Gag peptides and ex-
tends beyond pocket C. In HD-PTPCC, the side chains of K500,
Y501, and K685 form a high rim at the edge of this pocket (Fig-
ures 4 and 6), and the three-stranded coiled coil results in tight
packing between H4 and H7, leaving no room for a groove.
These structural features also explain why UBAP1C is displaced
toward pocket A with respect to the position of the Gag peptides
on Alix (Figure 6).2120 Structure 24, 2115–2126, December 6, 2016We believe that the differences in the architecture and
binding interface features observed between Alix and HD-
PTP are critical in determining ligand-binding selectivity. We
confirmed this by showing that in solution, AlixV does not
bind to the UBAP1C peptide, and that a Gag peptide (SIV-
GAG) does not bind to HD-PTPCC (Figure 7B), mirroring the
lack of binding of full-length UABP1 to AlixBro1-V (Stefani
et al., 2011). The conserved FYX2L motif is therefore neces-
sary for binding but insufficient to determine specific selec-
tivity between Bro1 proteins and their biological partners.
Instead, both the overall architecture and local structural de-
terminants appear to be key in defining molecular recognition
and binding specificity.
Functional Validation of HD-PTP-UBAP1 Interactions
The HD-PTPCC-UBAP1C interface was validated by RNAi rescue
experiments using HD-PTPBro1-CC and mutations at the binding
site. In normal cells, EGFR that has been activated by EGF
passes through the endosomal pathway and is degraded within
lysosomes. In contrast, cells depleted of HD-PTP are character-
ized by the accumulation of ligand-activated EGFR in highly clus-
tered early endosomes that label strongly for protein-ubiquitin
conjugates (Doyotte et al., 2008). We have previously shown
that reintroduction of HD-PTPBro1-CC is sufficient to rescue these
trafficking defects and represents the minimal functional region
of HD-PTP (Doyotte et al., 2008). HeLa cells depleted of HD-PTP
and pulsed for 3 hr with EGF, showed intense ubiquitin labeling
on cytoplasmic clusters (Figure 7C), which co-labeled with the
endosomal marker EEA1 as previously reported (Doyotte et al.,
2008) (data not shown). As expected, transfection of these cells
with WT HD-PTPBro1-CC restored a WT phenotype, in which
Figure 5. NMR Analysis of the HD-PTPCC-
UBAP1C Binding Interface
(A) Ha region of 1H13C-PUSH-HSQC of UBAP1C
(natural abundance 13C) in PBS-D2O showing the
resonance assignment.
(B) Ha region of 1H13C-HSQC of UBAP1C (natural
abundance 13C) in the presence of sub-stoichio-
metric HD-PTPCC. The D2O content in these
samples was approximately 80% and significant
intensity arises from H2O, compromising inter-
pretation of signals between 4.8 and 4.6 ppm.
Residues close in sequence to UBAP1 F268 are
significantly broadened by interaction with HD-
PTPCC. Residues C-terminal of UBAP1 D272 are
less affected by the presence of HD-PTPCC, and
therefore are identified as not being involved in the
binding site.
(C) Per residue mean peak intensity ratios between
UBAP1C samples containing paramagnetically (Iox)
and diamagnetically (Ired) labeled HD-PTPCC (C425,
C628), indicating the extent of paramagnetic
relaxation enhancement. For some resonances,
intensity ratios are low because of the line broad-
ening induced by binding, and these are marked by
red bars in the chart.
Error bars are SDs estimated from the noise level in
the HSQC spectra.ubiquitinated proteins were evenly distributed throughout the
cell (Figure 7C).
In contrast, the HD-PTPBro1-CC F678D mutant was unable to
rescue depletion of HD-PTP, with both transfected and untrans-
fected cells displaying strong ubiquitin labeling on cytoplasmic
inclusions (Figure 7C). The HD-PTPBro1-CC K671A mutant failed
to completely rescue a WT phenotype, but showed milder de-
fects than F678D (Figure 7D). Although K671 forms hydrogen
bond interactions with UBAP1C (Figures 4 and 6), its overall
contribution to binding affinity is clearly less critical when
compared with the contribution of the extensive hydrophobic
interactions of F678. These data extend our previous findings
(Stefani et al., 2011), confirm the functional significance of the
interface observed in the crystal structure, and, importantly,
demonstrate that binding of HD-PTP to UBAP1 is essential for
correct sorting of activated EGFR, since Alix does not function
in this ESCRT pathway.
DISCUSSION
The close functional cooperation between HD-PTP and UBAP1
is physiologically crucial. Disruption of this cooperation by abla-
tion or genetic defects leads to cancer, altered cell migration,
and neurological pathologies (Cheng et al., 1998; Kharitidi
et al., 2015; Qian et al., 2001; Rollinson et al., 2009). Our findings
explain the structural basis for the interaction between HD-PTP
and UBAP1 and reveal why UBAP1 binding is selective to HD-
PTP despite conservation of the FYX2L binding motif acrossStructuother Bro1 proteins. In addition, the
remarkably different architecture of the
HD-PTP CC domain compared with other
Bro1 proteins provides further insightsinto the assembly of specialized ESCRTs at the endosome that
drive downregulation of cell-surface receptors.
Our data show that HD-PTPCC adopts an open and extended
architecture, where the CC domain maintains a rigid conforma-
tion by virtue of the long central a helix. This structure contrasts
with the V-shaped CC domains of Alix and yeast Bro1 (Fisher
et al., 2007; Lee et al., 2007; Pashkova et al., 2013), and is
consistent with the low homology found between HD-PTPCC
and these V domains.
We revealed the structural determinants for specific inter-
action between HD-PTP and UBAP1 by X-ray crystallography,
NMR, and mutagenesis. Our results confirm that the conserved
HD-PTP residue F678 in the FYX2L motif is essential for binding
to UBAP1. Furthermore, key hydrophobic interactions between
UBAP1 residues F268, P269, and L271 (in the FPXL motif) and
HD-PTP residues F678, Y679, and L682 (in the FYX2L motif)
form the core of the binding interface. We demonstrated the
critical importance of F268 and F678 residues by mutagenesis,
binding analysis, and functional cellular assays.
Our findings match the reported roles of Alix F676, yeast Bro1
F687, and Rim20 F623 in binding to Gag late domains, Rfu1, and
Rim101, respectively (Fisher et al., 2007; Kimura et al., 2015; Lee
et al., 2007). Paradoxically, conservation of the FYX2L motif
in Bro1 proteins and that of the YPXnL motif in their biological
targets does not result in promiscuous interactions (Kimura
et al., 2015; Stefani et al., 2011). Our studies bring new insight
into understanding this paradox. Significant differences in the
sequence, local structural features, and hydrophobicity of there 24, 2115–2126, December 6, 2016 2121
Figure 6. Comparison of the Binding Sites
in the HD-PTPCC-UBAP1C, and Alix-Gag
Peptide Complexes
(A) Structures of Alix (gray ribbon) in complex with
HIV-Gag (magenta) and SIV-Gag (blue), super-
imposed on the structure of HD-PTPCC (gold
ribbon) in complex with UBAP1C (green). The
UBAP1C binding site is displaced with respect
to the Gag peptides that bind along a distal hy-
drophobic groove not conserved in HD-PTP.
Conversely, the closed conformation of the AlixV
domain prevents full access to the region near the
apex, making pocket A inaccessible.
(B) Enlarged view into the binding site of UBAP1c
(sticks) in HD-PTPCC (gold surface) and of the
complex of SIV-Gag peptide (blue ribbon) in AlixV
(gray surface). Only residues that interact are
shown. Pocket A and the high rim in HD-PTP that
closes off pocket C are labeled. In the complex of
AlixBro1-V with SIV-Gag, the binding site extends
toward a hydrophobic groove beyond pocket C,
but no binding occurs in the equivalent to pocket A
in HD-PTP.
(C) Detailed view of pocket A in HD-PTP (left, gold
ribbon) and Alix (right, gray ribbon) showing
the side chains in sticks. The lack of sequence
conservation in this pocket together with steric
hindrance may explain the lack of interactions of
the SIV-Gag peptide with Alix (right), whereas in
HD-PTP, pocket A provides several hydrophobic
interactions with residues in the UBAP1C peptide
(labeled) in addition to hydrogen bonds with K671
in HD-PTP.
(D) Detail view of pocket C showing the HD-PTP
residues that form the high rim that closes off
pocket C (left) and prevents binding of UBAP1C
peptide beyond this point. In contrast, SIV-Gag
forms interactions along a hydrophobic groove in
Alix (right) that extends beyond pocket C.UBAP1C binding site in HD-PTP, compared with that of the Gag
peptide site in Alix, are critical to determine specificity. Further-
more, the open architecture of HD-PTPCC is essential to enable
binding of UBAP1C to pocket A, which is inaccessible in the
V-shaped structure of Alix observed in the complexes with
Gag peptides. Thus, the conformational differences may provide
additional molecular determinants for the binding selectivity that
we observe.
AlixV has been reported to be flexible in solution and therefore
able to adopt a more open conformation (Pashkova et al., 2013;
Pires et al., 2009). However, we found no evidence that Alix
binds the UBAP1C peptide in our binding studies in solution, or
of binding to the full-length UBAP1 by Y2H (Stefani et al., 2011).
We hypothesize that differences in the overall architecture of
Bro1proteins, and in the local featuresat thebindingsite, combine
to elicit exquisite functional selectivity for ESCRT pathway regula-
tion. This is certainly the case for HD-PTP and Alix. Whether these
principles apply tootherBro1proteins and their targetswill require
further high-resolution analyses of their complexes.2122 Structure 24, 2115–2126, December 6, 2016We found that there is no evidence for
large-scale flexibility of HD-PTPCC, as
has been suggested for the V domainsof Alix (Fisher et al., 2007; Pires et al., 2009) and yeast Bro1
(Pashkova et al., 2013). In addition, the open conformation
exhibited by HD-PTPCC most likely extends to the entire Bro1-
CC region, since the UBAP1C peptide binds equally well to
HD-PTPCC and HD-PTPBro1-CC. Indeed, HD-PTPBro1-CC is func-
tionally competent as demonstrated by its binding to UBAP1 in
cells and its ability to rescue defects in EGFR sorting caused
by RNAi-mediated depletion of endogenous HD-PTP. Alto-
gether, these new findings point to fundamental differences in
howHD-PTP and Alix are regulated and how they control ESCRT
function to define pathway diversity at different sub-cellular
locations.
EXPERIMENTAL PROCEDURES
Cloning, Protein Expression, and Purification
Constructs for HD-PTPBro1 (1–361), HD-PTPCC (363–712), and AlixV (358–702)
were subcloned into a pNIC28a-Bsa4 vector (gift fromOpher Gileadi; Addgene
no. 26103). HD-PTPBro1-CC (1–714) was cloned into a pET28a vector with re-
striction sites Nde1 and Xho1. Point mutants were generated by quick-change
Figure 7. Biochemical and Functional
Validation of the UBAP1C Binding Interface
with HD-PTP
(A) Biosensor sensograms of the binding of HD-
PTPCC containing the F678D mutation to UBAP1C
peptide (left) and of binding of HD-PTPBro1-CC and
HD-PTPCC to UBAP1C peptide containing the
F268S substitution (center and right). Both muta-
tions abolished interaction.
(B) Binding to the CC domain is selective despite
conservation of the FYX2L motif in both Alix and
HD-PTPCC: UBAP1C does not bind to Alix and the
SIV-Gag peptide does not bind to HD-PTPCC.
(C) Cells depleted of HD-PTP were transiently
transfected with HA-tagged HD-PTPBro1-CC and
stimulated with EGF for 3 hr before fixing and
staining with anti-ubiquitin (Ub). Cells transfected
with WT HD-PTPBro1-CC display even ubiquitin
distribution throughout the cell, while un-
transfected cells or those transfected with the
F678D mutant display very strong accumula-
tions on cytoplasmic inclusions. These co-label
with endosomal markers as previously reported
(Doyotte et al., 2008) (data not shown). Scale
bar, 10 mm.
(D) Scoring of rescue experiments. Cells trans-
fected as indicated were scored for normal ubiq-
uitin distribution. One hundred cells from three
independent experiments were counted, and SDs
between these experiments are shown. Two-way
ANOVA analysis: F678D versus WT, p = 0.0025;
K671A versus WT, p = 0.043; K671A versus
F678D, p = 0.002.primers using Phusion DNA polymerase (New England Biolabs). Con-
structs were expressed in BL21(DE3) Escherichia coli using 0.1 mM iso-
propyl b-D-1 thiogalactopyranoside induction overnight at 20C. Cells
were lysed in 20 mM HEPES (pH 7.0), 500 mM NaCl, 10 mM imidazole,
2 mM phenylmethylsulfonyl fluoride by sonication, and the supernatant
was clarified by centrifugation at 12,400 3 g for 1 hr. Proteins were purified
by affinity chromatography using nickel-beads (QIAGEN) pre-equilibrated in
binding buffer (20 mM HEPES, 500 mM NaCl, 10 mM imidazole [pH 7.4])
followed by anion-exchange chromatography with a Mono Q 5/50 GL
column (GE Healthcare) in 20 mM HEPES (pH 7.4), 2 mM EDTA, 2 mM
DTT, and super elongation complex (SEC) using a Superdex200 column
(GE Healthcare) in the same buffer. Incorporation of L-selenomethionine
was achieved by growing a culture in M9 minimal medium (Molecular
Dimensions) supplemented with essential amino acids (100 mg/L each)
and selenomethionine (80 mg/L).
Crystallization and Structure Determination
For crystallization, the His6 tag of HD-PTPCC was removed by cleavage with
tobacco etch virus protease followed by nickel-affinity chromatography and
further purification as above. apo-HD-PTPCC (11 mg/mL) was crystallized
in 0.1 M Bis-Tris (pH 6.0), 0.1–0.2 M Na-formate, and 13%–15% PEG3350 at
21C. Crystals of the HD-PTPCC-UBAP1C complex were obtained by mixing
HD-PTPCC (1 mg/mL) with 1 mM UBAP1 peptide and concentrated to
11 mg/mL from a reservoir solution of 0.2 M KSCN, 20% PEG3350. All crystals
were cryo-protected in perfluoropolyether cryo oil (Hampton Research) prior to
freezing in liquid nitrogen. Data were collected at I02 and I03 beamlines in
Diamond Light Source (UK) and processed with XDS (Kabsch, 2010). The
structure of apo-HD-PTPCC was determined by selenium single-wavelength
anomalous diffraction (Se-SAD) using PHENIX AutoSol, and the initial model
built using PHENIX AutoBuild (Adams et al., 2010) and COOT (Emsley et al.,2010) and refined using PHENIX Refine. The structure of HD-PTPCC-UBAP1C
was determined by molecular replacement using the apo structure as the
search model using PHENIX Phaser and model building and refinement in
COOT and PHENIX Refine.
EPR-DEER Measurements
Proteins were purified as describe above. A 15-fold molar excess of MTSL
(Toronto Research Chemicals) was mixed with the protein sample and
incubated at 4C overnight followed by SEC on a Superdex200 column (GE
Healthcare) equilibrated in 20 mM HEPES, 250 mM NaCl, 5 mM EDTA
(pH 7.4). Labeling was confirmed by mass spectrometry. All mutants and the
WT were checked by circular dichroism to confirm the secondary structure
(Figure S1). DEER samples were prepared by buffer exchange into deuterated
buffer (20 mM HEPES, 250 mM NaCl, in D2O [pD 7.4]) with 30% (v/v) glycerol-
d8 to a final protein concentration of 60 mM and flash frozen in 4 mm quartz
tubes (Wilmad). The four-pulse DEER experiments were carried out on
a pulsed ELEXSYS E580 (9 GHz) spectrometer (Bruker), cooled to 50 K with
a continuous-flow helium CF935 cryostat and an isothermal calorimetry
502 temperature control system (Oxford Instruments) and analyzed with
DEERAnalysis 2013.2 (Jeschke et al., 2006). Distance distribution predictions
were calculated using MMM 2013.2 (Multiscale Modeling of Macromolecular
systems) (Polyhach et al., 2011).
Torsion-Angle Molecular Dynamics
CNS (Crystallography & NMR System, version 1.3) (Brunger et al., 1998) was
used to run torsion-angle molecular dynamics simulations (TAMDS) of
HD-PTPCC models with MTSL spin-labeled side chains at selected positions.
Torsional angle flexibility was limited to the MTSL side chains and the loop
regions between H1 and H2 (residues 42–58) and between H2 and H3 (resi-
dues 71–73), with the remaining residues treated as rigid. DEER distanceStructure 24, 2115–2126, December 6, 2016 2123
constraints were introduced between the nitrogen atoms of the MTSL groups:
42.4 ± 10 A˚ for C628-C425 and 61.7 ± 10 A˚ for C425-C697.
NMR and PRE Measurements
UBAP1C peptide was dissolved at a concentration of 1 mg/mL (0.5 mM) in
PBS in D2O [pD 7.5].
1H13C gradient-selected HSQC spectra were recorded
at natural abundance 13C (1%) at 800 MHz, using a Bruker AVANCE III spec-
trometer equipped with a TCI (1H-13C-15N/2H) cryoprobe with z gradients.
Pure-shift (PUSH) HSQC spectra (Paudel et al., 2013) were recorded for the
uncomplexed peptide. Assignment of the H-C correlations was by HSQC-
total correlation spectroscopy and nuclear Overhauser effect spectroscopy
spectra, and confirmed by the behavior in the protein complexes. Complexa-
tion with HD-PTPCC was detected with the addition of 60 mM of the protein.
PRE measurements were recorded by taking MTSL-labeled HD-PTPCC
C697S mutant under the same conditions, recording
1H13C HSQCs, and then
reducing the MTSL label (rendering it diamagnetic) with 10-fold excess of
sodium ascorbate (added from 1 M stock).
Biosensor Binding Studies
Binding studieswere performed at 25Con amultiplex systemProteOn XPR36
(Bio-Rad Laboratories) in 10mMHEPES (pH 7.4), 150mMNaCl, 0.05%Tween
20 as running buffer, with 50–100 mg/mL of protein immobilized on an HTE chip
(Bio-Rad Laboratories). Peptide solutions (50 mL) were injected at 100 mL/min.
Data were analyzed with ProteOn Manager software (Bio-Rad Laboratories),
using the equilibrium binding model: Response = [A] 3 Rmax/([A] + KD) where
[A] is the analyte concentration and Rmax is the maximum response.
Yeast Two-Hybrid Analysis
HD-PTPBro1-CC, HD-PTPBro1-CC F678D, and AlixBro1-V cloned into pGBKT7
were used as described previously (Stefani et al., 2011). UBAP1 (122–308)
was cloned into pGADT7. Further deletion and missense mutations in
UBAP1 as indicated were generated by standard PCR-based mutagenesis.
Interactions were tested using the Matchmaker Gold system (Clontech) as
described previously (Stefani et al., 2011) Each triplicate experiment was
repeated at least three times.
UBAP1 In Vitro Translation and Binding to HD-PTP
UBAP1-strep encoded on a pTriex5 vector (Stefani et al., 2011) was amplified
using Pwo Polymerase (Roche). UBAP1 RNA was synthesized from the PCR
product using T7 RNA polymerase (Promega). Protein was translated in
nuclease-treated rabbit reticulocyte lysate (Promega) containing 35S-methio-
nine (PerkinElmer), and 100 units of RNasin (Promega) for 1 hr at 30C, followed
by 10 min in the presence of 1 mM puromycin. Then 20 mL of translated protein
was incubatedwith 5 mgHis6- HD-PTPBro1-CC in 250 mL of immunoprecipitation
(IP) buffer (20mMHEPES [pH 7.4], 100mMNaCl, 1mMMgCl2, 1% [w/v] Triton
X-100) for 2 hr at 4C, thenovernightwith 3mLof anti-His antibody (CloneHIS-1,
Sigma). Samples were incubated with 20 mL of protein A-Sepharose beads
(Invitrogen) for 2 hr at 4C, then washed three times in IP buffer.
Mitochondrial Targeting Experiments
Mitochondrial targeting experiments were performed as previously described
(Sato et al., 2015). HeLa cells were transiently transfected with HD-PTPBro1-CC
containing an N-terminal FKBP sequence and a C-terminal myc tag (cloned
into pcDNA5), Mito-FRB (a gift from Martin Lowe, Manchester, UK), and either
GFP,WTUBAP1-GFP, or F268SUBAP1-GFP (in pEGFP).Mitochondrial reloca-
tion of FKBP-HD-PTPBro1-CC-myc was induced by addition of 1 mM rapamycin
(Sigma) for 3 hr. Cells were then prepared for immunofluorescence microscopy
as above. Mitochondrial relocation of GFP-tagged constructs was scored in
three independent experiments (100 cells counted per experiment).
Cell Culture, Transfection, and siRNA Rescue Experiments
HeLa cells were grown in DMEM with 1% NEAA, 10% fetal calf serum
(HyClone; Perbio) and 1% Pen-Strep Fugene 6 (Roche) was used for DNA
transfections. Interferin (QBiogene) was used for siRNA, using an HD-PTP
nucleotide as previously published (Doyotte et al., 2008), or a non-targeting
siRNA (Dharmacon) as a control. Efficient HD-PTP knockdown was confirmed
by western blotting, as previously reported (Doyotte et al., 2008). For siRNA
rescue experiments, cells were knocked down for 24 hr, then transfected2124 Structure 24, 2115–2126, December 6, 2016with WT or specified mutants of HD-PTPBro1-CC (note that the siRNA oligo
targets a C-terminal sequence within HD-PTP) for 48 hr. Rescues were as-
sessed by visual quantification of phenotypes. Cells containing clustered
and strongly labeled foci of FK2 staining (previously identified as endoso-
mal; Doyotte et al., 2008) were considered knocked down. Rescued cells
displayed a WT, diffuse cytoplasmic distribution of FK2 staining. Scoring
was performed for three independent experiments, with at least 100 trans-
fected cells examined each time. Data were subjected to statistical anal-
ysis (two-way ANOVA) using Prism5 software (GraphPad). For graphical
representation of rescue data, mean scores ± SD are provided for the three
determinations.
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